Fox Run Management, L.L.C. Ironwood Pharmaceuticals Inc Transaction History

Fox Run Management, L.L.C.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$5.58 - $8.61 $117,966 - $182,024	21,141 New	21,141 $137,000
Q1 2023 May 12, 2023	BUY	$10.37 - $12.56 $203,957 - $247,030	19,668 New	19,668 $206,000
Q3 2021 Nov 15, 2021	SELL	$11.92 - $13.92 $181,350 - $211,778	-15,214 Closed	0 $0
Q2 2021 Aug 05, 2021	BUY	$10.16 - $13.11 $154,574 - $199,455	15,214 New	15,214 $196,000
Q2 2018 Jul 17, 2018	SELL	$11.83 - $16.2 $148,691 - $203,617	-12,569 Closed	0 $0
Q1 2018 Apr 17, 2018	BUY	$11.13 - $13.63 $139,892 - $171,315	12,569 New	12,569 $194,000

238

162M

11.2M

9.1K

Ticker IRWD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 153,231,008
Market Cap $541M
Description
Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...

Get notified when there are updates to the investment portfolio of Fox Run Management, L.L.C., based on Form 13F filings with the SEC.

Stay updated on Fox Run Management, L.L.C. with notifications on news.